eRespiroConnect

eRespiroConnect is a comprehensive digital health solution designed to support the diagnosis, treatment, and monitoring of Tuberculosis (TB) and other lung diseases and conditions, including Pneumonia, Chronic Obstructive Pulmonary Disease (COPD), Asthma, Pneumoconiosis, Lung Cancer, and Cardiomegaly. The app enables healthcare providers to register patients, document their complete treatment journey, and improve treatment adherence and outcomes. With features such as resistance profile creation, treatment regimen tracking, diagnostic test recording, and structured monthly clinical follow-ups, eRespiroConnect provides a holistic, data-driven approach to respiratory disease management. From patient enrolment to final treatment outcomes, the app provides a centralized platform for storing medical data, monitoring progress, and ensuring timely interventions. Its user-friendly interface supports real-time access to essential information while maintaining data security and confidentiality. The platform is especially valuable in resource-limited or high TB-burden settings, allowing health workers, clinicians, and program managers to make informed decisions and coordinate care more effectively. By enabling seamless communication across healthcare tiers and generating actionable insights, eRespiroConnect contributes to the national and global fight against TB and other lung diseases. Designed with a strong public health focus, this app not only helps reduce treatment default rates but also enhances patient follow-up and case management, supporting national respiratory health programs and aligning with international standards for TB control and non-communicable disease management. Used in community-based settings, eRespiroConnect empowers healthcare teams to deliver better care, improve patient outcomes, and digitally transform respiratory healthcare systems.